Cargando…

Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure

Metabolic remodeling plays an important role in the pathophysiology of heart failure (HF). We sought to characterize metabolic remodeling and implicated signaling pathways in two rat models of early systolic dysfunction (MOD), and overt systolic HF (SHF). Tandem mass tag-labeled shotgun proteomics,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaanine, Antoine H., Higgins, LeeAnn, Markowski, Todd, Harman, Jarrod, Kachman, Maureen, Burant, Charles, Navar, L. Gabriel, Busija, David, Delafontaine, Patrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745344/
https://www.ncbi.nlm.nih.gov/pubmed/35008662
http://dx.doi.org/10.3390/ijms23010235
_version_ 1784630322923569152
author Chaanine, Antoine H.
Higgins, LeeAnn
Markowski, Todd
Harman, Jarrod
Kachman, Maureen
Burant, Charles
Navar, L. Gabriel
Busija, David
Delafontaine, Patrice
author_facet Chaanine, Antoine H.
Higgins, LeeAnn
Markowski, Todd
Harman, Jarrod
Kachman, Maureen
Burant, Charles
Navar, L. Gabriel
Busija, David
Delafontaine, Patrice
author_sort Chaanine, Antoine H.
collection PubMed
description Metabolic remodeling plays an important role in the pathophysiology of heart failure (HF). We sought to characterize metabolic remodeling and implicated signaling pathways in two rat models of early systolic dysfunction (MOD), and overt systolic HF (SHF). Tandem mass tag-labeled shotgun proteomics, phospho-(p)-proteomics, and non-targeted metabolomics analyses were performed in left ventricular myocardium tissue from Sham, MOD, and SHF using liquid chromatography–mass spectrometry, n = 3 biological samples per group. Mitochondrial proteins were predominantly down-regulated in MOD (125) and SHF (328) vs. Sham. Of these, 82% (103/125) and 66% (218/328) were involved in metabolism and respiration. Oxidative phosphorylation, mitochondrial fatty acid β-oxidation, Krebs cycle, branched-chain amino acids, and amino acid (glutamine and tryptophan) degradation were highly enriched metabolic pathways that decreased in SHF > MOD. Glycogen and glucose degradation increased predominantly in MOD, whereas glycolysis and pyruvate metabolism decreased predominantly in SHF. PKA signaling at the endoplasmic reticulum–mt interface was attenuated in MOD, whereas overall PKA and AMPK cellular signaling were attenuated in SHF vs. Sham. In conclusion, metabolic remodeling plays an important role in myocardial remodeling. PKA and AMPK signaling crosstalk governs metabolic remodeling in progression to SHF.
format Online
Article
Text
id pubmed-8745344
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87453442022-01-11 Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure Chaanine, Antoine H. Higgins, LeeAnn Markowski, Todd Harman, Jarrod Kachman, Maureen Burant, Charles Navar, L. Gabriel Busija, David Delafontaine, Patrice Int J Mol Sci Article Metabolic remodeling plays an important role in the pathophysiology of heart failure (HF). We sought to characterize metabolic remodeling and implicated signaling pathways in two rat models of early systolic dysfunction (MOD), and overt systolic HF (SHF). Tandem mass tag-labeled shotgun proteomics, phospho-(p)-proteomics, and non-targeted metabolomics analyses were performed in left ventricular myocardium tissue from Sham, MOD, and SHF using liquid chromatography–mass spectrometry, n = 3 biological samples per group. Mitochondrial proteins were predominantly down-regulated in MOD (125) and SHF (328) vs. Sham. Of these, 82% (103/125) and 66% (218/328) were involved in metabolism and respiration. Oxidative phosphorylation, mitochondrial fatty acid β-oxidation, Krebs cycle, branched-chain amino acids, and amino acid (glutamine and tryptophan) degradation were highly enriched metabolic pathways that decreased in SHF > MOD. Glycogen and glucose degradation increased predominantly in MOD, whereas glycolysis and pyruvate metabolism decreased predominantly in SHF. PKA signaling at the endoplasmic reticulum–mt interface was attenuated in MOD, whereas overall PKA and AMPK cellular signaling were attenuated in SHF vs. Sham. In conclusion, metabolic remodeling plays an important role in myocardial remodeling. PKA and AMPK signaling crosstalk governs metabolic remodeling in progression to SHF. MDPI 2021-12-26 /pmc/articles/PMC8745344/ /pubmed/35008662 http://dx.doi.org/10.3390/ijms23010235 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chaanine, Antoine H.
Higgins, LeeAnn
Markowski, Todd
Harman, Jarrod
Kachman, Maureen
Burant, Charles
Navar, L. Gabriel
Busija, David
Delafontaine, Patrice
Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure
title Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure
title_full Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure
title_fullStr Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure
title_full_unstemmed Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure
title_short Multi-Omics Approach Profiling Metabolic Remodeling in Early Systolic Dysfunction and in Overt Systolic Heart Failure
title_sort multi-omics approach profiling metabolic remodeling in early systolic dysfunction and in overt systolic heart failure
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745344/
https://www.ncbi.nlm.nih.gov/pubmed/35008662
http://dx.doi.org/10.3390/ijms23010235
work_keys_str_mv AT chaanineantoineh multiomicsapproachprofilingmetabolicremodelinginearlysystolicdysfunctionandinovertsystolicheartfailure
AT higginsleeann multiomicsapproachprofilingmetabolicremodelinginearlysystolicdysfunctionandinovertsystolicheartfailure
AT markowskitodd multiomicsapproachprofilingmetabolicremodelinginearlysystolicdysfunctionandinovertsystolicheartfailure
AT harmanjarrod multiomicsapproachprofilingmetabolicremodelinginearlysystolicdysfunctionandinovertsystolicheartfailure
AT kachmanmaureen multiomicsapproachprofilingmetabolicremodelinginearlysystolicdysfunctionandinovertsystolicheartfailure
AT burantcharles multiomicsapproachprofilingmetabolicremodelinginearlysystolicdysfunctionandinovertsystolicheartfailure
AT navarlgabriel multiomicsapproachprofilingmetabolicremodelinginearlysystolicdysfunctionandinovertsystolicheartfailure
AT busijadavid multiomicsapproachprofilingmetabolicremodelinginearlysystolicdysfunctionandinovertsystolicheartfailure
AT delafontainepatrice multiomicsapproachprofilingmetabolicremodelinginearlysystolicdysfunctionandinovertsystolicheartfailure